BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36914110)

  • 1. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.
    Zhang X; Liang F; Li T; Jiang Y; Ren F
    Arch Biochem Biophys; 2023 May; 739():109568. PubMed ID: 36914110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperoside Ameliorates Renal Tubular Oxidative Damage and Calcium Oxalate Deposition in Rats through AMPK/Nrf2 Signaling Axis.
    Tian H; Liang Q; Shi Z; Zhao H
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():5445548. PubMed ID: 36942317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2/HO-1 in the mouse model of stone formation.
    Zhou D; Wu Y; Yan H; Shen T; Li S; Gong J; Li G; Mai H; Wang D; Tan X
    Phytomedicine; 2022 Nov; 106():154429. PubMed ID: 36099652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of Incarvillea diffusa Royle extract in the formation of calcium oxalate nephrolithiasis by regulating ROS-induced Nrf2/HO-1 pathway in rats.
    Gao M; Meng T; Chen F; Peng M; Li Q; Li L; Yang L; Yan Y; Deng T; Pan X; Luo Z; Yang J; Yang X
    J Ethnopharmacol; 2024 May; 325():117619. PubMed ID: 38272103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho inhibits the formation of calcium oxalate stones by regulating the Keap1-Nrf2-ARE signaling pathway.
    Ahmatjan B; Ruotian L; Rahman A; Bin M; Heng D; Yi H; Tao C; le G; Mahmut M
    Int Urol Nephrol; 2023 Feb; 55(2):263-276. PubMed ID: 36336747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization.
    Lu H; Sun X; Jia M; Sun F; Zhu J; Chen X; Chen K; Jiang K
    Oxid Med Cell Longev; 2021; 2021():5527137. PubMed ID: 34691355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress.
    Qin B; Wang Q; Lu Y; Li C; Hu H; Zhang J; Wang Y; Zhu J; Zhu Y; Xun Y; Wang S
    Oxid Med Cell Longev; 2018; 2018():1271864. PubMed ID: 29849862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of
    Deng JW; Li CY; Huang YP; Liu WF; Zhang Q; Long J; Wu WQ; Huang LH; Zeng GH; Sun XY
    J Agric Food Chem; 2024 Mar; 72(12):6372-6388. PubMed ID: 38471112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway.
    Yuan P; Sun X; Liu X; Hutterer G; Pummer K; Hager B; Ye Z; Chen Z
    Phytomedicine; 2021 Jun; 86():153555. PubMed ID: 33852977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney.
    Duan X; Kong Z; Mai X; Lan Y; Liu Y; Yang Z; Zhao Z; Deng T; Zeng T; Cai C; Li S; Zhong W; Wu W; Zeng G
    Redox Biol; 2018 Jun; 16():414-425. PubMed ID: 29653411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice.
    Li Y; Zhang J; Liu H; Yuan J; Yin Y; Wang T; Cheng B; Sun S; Guo Z
    Phytomedicine; 2019 Aug; 61():152861. PubMed ID: 31029908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
    Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
    Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of AT1R/IP3/IP3R-mediated Ca
    Hong SY; Yang YY; Wang SG; Qin BL
    Chem Biol Interact; 2023 Sep; 382():110636. PubMed ID: 37454925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis in calcium oxalate kidney stone formation and the possible regulatory mechanism of ANKRD1.
    Zhao J; Wu Y; Zhou K; Huang M; Sun Y; Kang J; Su Q; Zhao Y; Liu Q; Li C
    Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119452. PubMed ID: 36907445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin 4 Gene Silencing Reduces Oxidative Stress and Calcium Oxalate Crystal Formation in Renal Tubular Epithelial Cells Through the Extracellular Signal-Regulated Kinase Signaling Pathway in Nephrolithiasis Rat Model.
    Sun L; Zou LX; Wang J; Chen T; Han YC; Zhu DD; Zhuo SC
    Kidney Blood Press Res; 2018; 43(3):820-835. PubMed ID: 29843125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury.
    Ye QL; Wang DM; Wang X; Zhang ZQ; Tian QX; Feng SY; Zhang ZH; Yu DX; Ding DM; Xie DD
    Chem Biol Interact; 2021 Sep; 347():109605. PubMed ID: 34333021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB1 protects against the renal injury in a rat model of kidney stone disease and calcium oxalate monohydrate crystals-induced injury in NRK-52E cells.
    Yu L; Gan X; Bai Y; An R
    Toxicol Appl Pharmacol; 2021 Feb; 413():115394. PubMed ID: 33421503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: a possible role of oxidative stress in nephrolithiasis.
    Davalos M; Konno S; Eshghi M; Choudhury M
    J Endourol; 2010 Mar; 24(3):339-45. PubMed ID: 20210657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allicin attenuates calcium oxalate crystal deposition in the rat kidney by regulating gap junction function.
    Lai Y; Liang X; Zhong F; Wu W; Zeng T; Huang J; Duan X; Li S; Zeng G; Wu W
    J Cell Physiol; 2019 Jun; 234(6):9640-9651. PubMed ID: 30378099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    An L; Wu W; Li S; Lai Y; Chen D; He Z; Chang Z; Xu P; Huang Y; Lei M; Jiang Z; Zeng T; Sun X; Sun X; Duan X; Wu W
    Oxid Med Cell Longev; 2021; 2021():9949697. PubMed ID: 34336124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.